AZD7325

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2018
01220122018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Anxiolytic activity has been associated with GABAA α2 and α3 subunits. Several target compounds were identified and required in C… (More)
Is this relevant?
2018
2018
AZD7325 [4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide] is a selective GABAAα2,3 receptor modulator… (More)
  • table 1
  • table 2
Is this relevant?
2016
2016
Sedation, dependence, and abuse liability limit the use of non-selective γ-aminobutyric acid (GABAA) receptor positive modulators… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Compounds with selectivity for GABAA receptor subtypes may differ significantly from nonselective benzodiazepines in their… (More)
  • figure 1
  • table 1
Is this relevant?
2014
2014
WHAT IS KNOWN AND OBJECTIVE AZD7325 is a selective gamma-amino-butyric acid (GABAA )α2, 3 receptor modulator. The aims of this… (More)
Is this relevant?
2014
2014
AIMS AZD7325 is a novel α2,3 -subtype-selective partial GABA-A-receptor modulator. This study investigated the pharmacodynamics… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2012
2012
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • AZD7325 is an orally administered, potent, selective gamma-amino-butyric acid (GABA(A… (More)
Is this relevant?